Coenzyme Q10 remarkably improves the bio-energetic function of rat liver mitochondria treated with statins

European Journal of Pharmacology

Volumn 762, Issue , 2015, Pages 270-274

  Mohammadi Bardbori, Afshin ^a   Najibi, Asma ^a   Amirzadegan, Najmeh ^a   Gharibi, Raziyeh ^a   Dashti, Ayat ^a   Omidi, Mahmoud ^a   Saeedi, Arastoo ^a   Ghafarian Bahreman, Ali ^a   Niknahad, Hossein ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atorvastatin; Coenzyme Q10; HFD (high fat diet); HMG CoA reductase inhibitors; Mitotoxicity; Simvastatin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ATORVASTATIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; SIMVASTATIN; SUCCINATE DEHYDROGENASE; TRIACYLGLYCEROL; UBIDECARENONE; CARRIER PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; UBIQUINONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENERGY METABOLISM; ENZYME ACTIVITY; LIPID DIET; LIVER MITOCHONDRION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRIAL RESPIRATION; NONHUMAN; PRIORITY JOURNAL; RAT; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD ANALYSIS; DRUG EFFECTS; METABOLISM; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; BLOOD CHEMICAL ANALYSIS; DIET, HIGH-FAT; DRUG SYNERGISM; ENERGY METABOLISM; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, LIVER; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; UBIQUINONE;

EID: 84931273605     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.05.041     Document Type: Article

References (51)

1. F. Aberg, E.L. Appelkvist, G. Dallner, and L. Ernster Distribution and redox state of ubiquinones in rat and human tissues Arch. Biochem. Biophys. 295 1992 230 234
2. R. Alleva, M. Tomasetti, S. Bompadre, and G.P. Littarru Oxidation of LDL and their subfractions: kinetic aspects and CoQ10 content Mol. Asp. Med. 18 Suppl 1997 S105 S112
3. G. Balercia, G. Arnaldi, F. Fazioli, M. Serresi, R. Alleva, A. Mancini, F. Mosca, G.R. Lamonica, F. Mantero, and G.P. Littarru Coenzyme Q10 levels in idiopathic and varicocele-associated asthenozoospermia Andrologia 34 2002 107 111
4. A.M. Bargossi, G. Grossi, P.L. Fiorella, A. Gaddi, R. Di Giulio, and M. Battino Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors Mol. Asp. Med. 15 Suppl 1994 S187 S193
5. P. Bernardi, R. Colonna, P. Costantini, O. Eriksson, E. Fontaine, F. Ichas, S. Massari, A. Nicolli, V. Petronilli, and L. Scorrano The mitochondrial permeability transition Biofactors 8 1998 273 281
6. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
7. G. Caso, P. Kelly, M.A. McNurlan, and W.E. Lawson Effect of coenzyme q10 on myopathic symptoms in patients treated with statins Am. J. Cardiol. 99 2007 1409 1412
8. J. Charan, and N.D. Kantharia How to calculate sample size in animal studies? J. Pharmacol. Pharmacother. 4 2013 303 306
9. A. Constantinescu, J.J. Maguire, and L. Packer Interactions between ubiquinones and vitamins in membranes and cells Mol. Asp. Med. 15 Suppl 1994 S57 S65
10. N. Cornelius, C. Byron, I. Hargreaves, P.F. Guerra, A.K. Furdek, J. Land, W.W. Radford, F. Frerman, T.J. Corydon, N. Gregersen, and R.K. Olsen Secondary coenzyme Q10 deficiency and oxidative stress in cultured fibroblasts from patients with riboflavin responsive multiple Acyl-CoA dehydrogenation deficiency Hum. Mol. Genet. 22 2013 3819 3827
11. F.L. Crane Biochemical functions of coenzyme Q10 J. Am. Coll. Nutr. 20 2001 591 598
12. G. De Pinieux, P. Chariot, M. Ammi-Said, F. Louarn, J.L. Lejonc, A. Astier, B. Jacotot, and R. Gherardi Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio Br. J. Clin. Pharmacol. 42 1996 333 337
13. N. Delanty, and M.A. Dichter Oxidative injury in the nervous system Acta Neurol. Scand. 98 1998 145 153
14. J.P. Desager, and Y. Horsmans Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors Clin. Pharmacokinet. 31 1996 348 371
15. J.W. Elrod, R. Wong, S. Mishra, R.J. Vagnozzi, B. Sakthievel, S.A. Goonasekera, J. Karch, S. Gabel, J. Farber, T. Force, J.H. Brown, E. Murphy, and J.D. Molkentin Cyclophilin D controls mitochondrial pore-dependent Ca(2+) exchange, metabolic flexibility, and propensity for heart failure in mice J. Clin. Investig. 120 2010 3680 3687
16. L. Ernster, and G. Dallner Biochemical, physiological and medical aspects of ubiquinone function Biochim. Biophys. Acta 1271 1995 195 204
17. L. Ernster, and P. Forsmark-Andree Ubiquinol: an endogenous antioxidant in aerobic organisms Clin. Investig. 71 1993 S60 S65
18. J.A. Farmer Aggressive lipid therapy in the statin era Prog. Cardiovasc. Dis. 41 1998 71 94
19. K. Folkers, P. Langsjoen, R. Willis, P. Richardson, L.J. Xia, C.Q. Ye, and H. Tamagawa Lovastatin decreases coenzyme Q levels in humans Proc. Natl. Acad. Sci. USA 87 1990 8931 8934
20. F. Forner, L.J. Foster, S. Campanaro, G. Valle, and M. Mann Quantitative proteomic comparison of rat mitochondria from muscle, heart, and liver Mol. Cell. Proteomics 5 2006 608 619
21. P. Forsmark-Andree, C.P. Lee, G. Dallner, and L. Ernster Lipid peroxidation and changes in the ubiquinone content and the respiratory chain enzymes of submitochondrial particles Free Radic. Biol. Med. 22 1997 391 400
22. M. Ghazi-Khansari, A. Mohammadi-Bardbori, and M.J. Hosseini Using Janus green B to study paraquat toxicity in rat liver mitochondria: role of ACE inhibitors (thiol and nonthiol ACEi) Ann. N. Y. Acad. Sci. 1090 2006 98 107
23. G. Ghirlanda, A. Oradei, A. Manto, S. Lippa, L. Uccioli, S. Caputo, A.V. Greco, and G.P. Littarru Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study J. Clin. Pharmacol. 33 1993 226 229
24. S.M. Grundy HMG-CoA reductase inhibitors for treatment of hypercholesterolemia N. Engl. J. Med. 319 1988 24 33
25. A.P. Halestrap What is the mitochondrial permeability transition pore? J. Mol. Cell. Cardiol. 46 2009 821 831
26. R.A. Haworth, and D.R. Hunter The Ca2+-induced membrane transition in mitochondria II. Nature of the Ca2+ trigger site Arch. Biochem. Biophys. 195 1979 460 467
27. J.M. Hodgson, G.F. Watts, D.A. Playford, V. Burke, and K.D. Croft Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes Eur. J. Clin. Nutr. 56 2002 1137 1142
28. D.P. Jones Determination of pyridine dinucleotides in cell extracts by high-performance liquid chromatography J. Chromatogr. 225 1981 446 449
29. G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial membrane permeabilization in cell death Physiol. Rev. 87 2007 99 163
30. R. Laaksonen, K. Jokelainen, T. Sahi, M.J. Tikkanen, and J.J. Himberg Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans Clin. Pharmacol. Ther. 57 1995 62 66
31. R. Laaksonen, J.P. Ojala, M.J. Tikkanen, and J.J. Himberg Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors Eur. J. Clin. Pharmacol. 46 1994 313 317
32. A.P. Lea, and D. McTavish Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias Drugs 53 1997 828 847
33. A. Mancini, B. Conte, L. De Marinis, M.E. Hallgass, D. Pozza, A. Oradei, and G.P. Littarru Coenzyme Q10 levels in human seminal fluid: diagnostic and clinical implications Mol. Asp. Med. 15 Suppl 1994 S249 S255
34. D. Marks, M. Thorogood, H.A. Neil, and S.E. Humphries A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia Atherosclerosis 168 2003 1 14
35. P. Mitchell The protonmotive Q cycle: a general formulation FEBS Lett. 59 1975 137 139
36. Y. Miyake, A. Shouzu, M. Nishikawa, T. Yonemoto, H. Shimizu, S. Omoto, T. Hayakawa, and M. Inada Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients Arzneimittelforschung 49 1999 324 329
37. A. Mohammadi-Bardbori, and M. Ghazi-Khansari Comparative measurement of cyanide and paraquat mitochondrial toxicity using two different mitochondrial toxicity assays Toxicol. Mech. Methods 17 2007 87 91
38. V.K. Mootha, J. Bunkenborg, J.V. Olsen, M. Hjerrild, J.R. Wisniewski, E. Stahl, M.S. Bolouri, H.N. Ray, S. Sihag, M. Kamal, N. Patterson, E.S. Lander, and M. Mann Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria Cell 115 2003 629 640
39. S.A. Mortensen, A. Leth, E. Agner, and M. Rohde Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors Mol. Asp. Med. 18 Suppl 1997 S137 S144
40. P. Navas, D.M. Fernandez-Ayala, S.F. Martin, G. Lopez-Lluch, R. De Caboa, J.C. Rodriguez-Aguilera, and J.M. Villalba Ceramide-dependent caspase 3 activation is prevented by coenzyme Q from plasma membrane in serum-deprived cells Free Radic. Res. 36 2002 369 374
41. J.J. Nawarskas HMG-CoA reductase inhibitors and coenzyme Q10 Cardiol. Rev. 13 2005 76 79
42. D.A. Playford, G.F. Watts, K.D. Croft, and V. Burke Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes Atherosclerosis 168 2003 169 179
43. G.L. Plosker, C.I. Dunn, and D.P. Figgitt Cerivastatin: a review of its pharmacological properties and therapeutic efficacy in the management of hypercholesterolaemia Drugs 60 2000 1179 1206
44. S. Ranganathan, A.M. Nambudiri, and H. Rudney The regulation of ubiquinone synthesis in fibroblasts: the effect of modulators of beta-hydroxy-beta-methylglutaryl-coenzyme A reductase activity Arch. Biochem. Biophys. 210 1981 592 597
45. C.W. Shults Therapeutic role of coenzyme Q(10) in Parkinson's disease Pharmacol. Ther. 107 2005 120 130
46. B.A. Taylor, L. Lorson, C.M. White, and P.D. Thompson A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy Atherosclerosis 238 2015 329 335
47. M. Turunen, J. Olsson, and G. Dallner Metabolism and function of coenzyme Q Biochim. Biophys. Acta 1660 2004 171 199
48. J.M. Villalba, F. Navarro, F. Cordoba, A. Serrano, A. Arroyo, F.L. Crane, and P. Navas Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport Proc. Natl. Acad. Sci. USA 92 1995 4887 4891
49. G.F. Watts, C. Castelluccio, C. Rice-Evans, N.A. Taub, H. Baum, and P.J. Quinn Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin J. Clin. Pathol. 46 1993 1055 1057
50. G.F. Watts, D.A. Playford, K.D. Croft, N.C. Ward, T.A. Mori, and V. Burke Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus Diabetologia 45 2002 420 426
51. F. Zhang, Z. Xu, J. Gao, B. Xu, and Y. Deng In vitro effect of manganese chloride exposure on energy metabolism and oxidative damage of mitochondria isolated from rat brain Environ. Toxicol. Pharmacol. 26 2008 232 236